國家衛生研究院 NHRI:Item 3990099045/15313
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12340/13512 (91%)
造访人次 : 2256807      在线人数 : 287
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15313


    题名: Reply to the Letter to the Editor: "Glucagon-like Peptide-1 Receptor Agonists: Best Choice for Patients with Cirrhosis and Diabetes?"
    作者: Yen, FS;Yu, TS;Hsu, CC;Hwu, CM
    贡献者: National Center for Geriatrics and Welfare Research;Institute of Population Health Sciences
    摘要: We greatly appreciate the comments 1 by Yuanyuan Li and Xiaoze Wang on our paper “Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes”. 2 It looks interesting and practical to compare similarity and difference of disease progress between the Simon’s study 3 [cirrhosis mainly caused by nonalcoholic fatty liver disease (NAFLD)] and ours [cirrhosis mainly caused by hepatitis B or C virus infection]. The authors expressed concerns about the nonsignificant difference in the risk of decompensated cirrhosis and hepatic encephalopathy between glucagon-like peptide-1 receptor agonist (GLP-1 RA) users and nonusers after using competing risk analysis with death as the competing risk in our study. We acknowledge these concerns. However, we believe that the lack of statistical significance may be due to the small number of patients (467) after propensity score matching (PSM), resulting in fewer cases of decompensated cirrhosis and hepatic encephalopathy. Instead of PSM, we used the inverse probability of treatment weighting (IPTW) as a covariate adjusted in the regression models to preserve sample size; then, using death as a competing risk, we performed competing risk-adjusted analyses in risk assessment of decompensated cirrhosis and hepatic encephalopathy between GLP-1 RA users and nonusers.
    日期: 2024-05
    關聯: Clinical Gastroenterology and Hepatology. 2024 May;22(5):1143-1144.e1.
    Link to: http://dx.doi.org/10.1016/j.cgh.2023.09.017
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1542-3565&DestApp=IC2JCR
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85177029951
    显示于类别:[許志成] 期刊論文
    [許志成] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB37741301.pdf565KbAdobe PDF106检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈